{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:10:14Z","timestamp":1775279414031,"version":"3.50.1"},"reference-count":15,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2026]]},"DOI":"10.3960\/jslrt.25069","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T22:08:12Z","timestamp":1769638092000},"page":"75-79","source":"Crossref","is-referenced-by-count":0,"title":["Composite lymphoma comprising adult T-cell leukemia\/lymphoma and Epstein\u2013Barr virus-positive primary central nervous system lymphoma"],"prefix":"10.3960","volume":"66","author":[{"given":"Kohtaro","family":"Toyama","sequence":"first","affiliation":[{"name":"Department of Hematology, Fujioka General Hospital, Fujioka, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genya","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Hematology, Gunma University Hospital, Maebashi, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manato","family":"Sugisaki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fujioka General Hospital, Fujioka, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Takei","sequence":"additional","affiliation":[{"name":"Department of Hematology, Gunma University Hospital, Maebashi, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatomo","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fujioka General Hospital, Fujioka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Niino D, Luong TMH, Miura S, Nakashima M, Iwanaga M. Incidence patterns of sequential or composite lymphoma: a population-based cancer registry study. Tohoku J Exp Med. 2021; 254: 123-127.","DOI":"10.1620\/tjem.254.123"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Tobinai K, Ohtsu T, Hayashi M <i>et al.<\/i> Epstein-Barr virus (EBV) genome carrying monoclonal B-cell lymphoma in a patient with adult T-cell leukemia-lymphoma. Leuk Res. 1991; 15: 837-846.","DOI":"10.1016\/0145-2126(91)90468-9"},{"key":"3","unstructured":"3 Tanaka Y, Kondo T, Kishimoto W <i>et al.<\/i> Epstein-Barr virus associated B cell lymphoproliferative disorder complicated in adult T-cell leukemia [Article in Japanese]. Rinsho Ketsueki. 2008; 49: 263-269."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Sakai T, Miyoshi T, Nesumi N, Nagai K. Composite lymphoma of adult T-cell leukemia\/lymphoma and diffuse large B-cell lymphoma with abrupt onset of ascites and pleural effusion. J Jpn Soc Int Med. 2012; 101: 766-768.","DOI":"10.2169\/naika.101.766"},{"key":"5","unstructured":"5 Nishida Y, Hyakuna Y, Fujisawa K <i>et al.<\/i> Composite lymphoma consisting of adult T-cell leukemia-lymphoma and diffuse large B-cell lymphoma [Article in Japanese]. Rinsho Ketsueki. 2013; 54: 2062-2067."},{"key":"6","unstructured":"6 Sakamoto H, Imaizumi Y, Niino D <i>et al.<\/i> Composite adult T-cell leukemia\/lymphoma and Epstein-Barr virus-positive diffuse large B-cell lymphoma [Article in Japanese]. Rinsho Ketsueki. 2020; 61: 305-311."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Amano M, Marutsuka K, Sugimoto T, Todaka T, Setoyama M. Epstein\u2013Barr virus-associated primary central nervous system lymphoma in a patient with adult T-cell leukemia\/lymphoma. J Dermatol. 2011; 38: 575-580.","DOI":"10.1111\/j.1346-8138.2010.01120.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Tamaki T, Karube K, Sakihama S <i>et al.<\/i> A Comprehensive Study of the Immunophenotype and its Clinicopathologic Significance in Adult T-Cell Leukemia\/Lymphoma. Mod Pathol. 2023; 36: 100169.","DOI":"10.1016\/j.modpat.2023.100169"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Gagnier JJ, Kienle G, Altman DG <i>et al.<\/i> The CARE guidelines: consensus-based clinical case reporting guideline development. J Clin Epidemiol. 2014; 67: 46-51.","DOI":"10.1016\/j.jclinepi.2013.08.003"},{"key":"10","unstructured":"10 Coupland SE, Ferry JA, Batchelar T, <i>et al.<\/i>: Primary large B-cell lymphoma of immune privileged sites. In: Swerdlow SH, Campo E, Harris NL, <i>et al.<\/i> (eds): WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. 5th ed, Part B, Lyon, International Agency for Research on Cancer. 2024; pp. 509-516."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Karube K, Aoki R, Sugita Y <i>et al.<\/i> The relationship of FOXP3 expression and clinicopathological characteristics in adult T-cell leukemia\/lymphoma. Mod Pathol. 2008; 21: 617-625.","DOI":"10.1038\/modpathol.2008.25"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Satou Y, Matsuoka M. HTLV-1 and the host immune system: how the virus disrupts immune regulation, leading to HTLV-1 associated diseases. J Clin Exp Hematopathol. 2010; 50: 1-8.","DOI":"10.3960\/jslrt.50.1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Gandhi MK, Hoang T, Law SC <i>et al.<\/i> EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity. Blood. 2021; 137: 1468-1477.","DOI":"10.1182\/blood.2020008520"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Pipkin S, Scheer S, Okeigwe I <i>et al.<\/i> The effect of HAART and calendar period on Kaposi\u2019s sarcoma and non-Hodgkin lymphoma: results of match between an AIDS and cancer registry. AIDS. 2011; 25: 463-471.","DOI":"10.1097\/QAD.0b013e32834344e6"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Lurain K, Uldrick TS, Ramaswami R <i>et al.<\/i> Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate. Blood. 2020; 136: 2229-2232.","DOI":"10.1182\/blood.2020006048"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/66\/1\/66_25069\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:31:05Z","timestamp":1775277065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/66\/1\/66_25069\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.25069","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"25069"}}